Pacer Advisors, Inc. Clovis Oncology, Inc. Transaction History

Pacer Advisors, Inc.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jul 21, 2021	SELL	$5.02 - $7.05 $65,917 - $92,573	-13,131 Closed	0 $0
Q1 2021 Apr 05, 2021	SELL	$4.81 - $10.34 $68,099 - $146,393	-14,158 Reduced 51.88%	13,131 $92,000
Q4 2020 Jan 20, 2021	BUY	$4.13 - $6.41 $48,477 - $75,240	11,738 Added 75.48%	27,289 $131,000
Q3 2020 Oct 19, 2020	BUY	$4.82 - $7.72 $74,955 - $120,053	15,551 New	15,551 $91,000
Q4 2018 Feb 13, 2019	SELL	$11.63 - $32.67 $89,411 - $251,166	-7,688 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$29.37 - $49.48 $225,796 - $380,402	7,688 New	7,688 $226,000
Q1 2018 May 14, 2018	SELL	$50.12 - $67.72 $83,048 - $112,212	-1,657 Closed	0 $0
Q4 2017 Feb 14, 2018	SELL	$57.69 - $84.58 $354,043 - $519,067	-6,137 Reduced 78.74%	1,657 $113,000
Q3 2017 Nov 08, 2017	BUY	$67.17 - $84.81 $523,522 - $661,009	7,794	7,794 $642,000

166

Ticker CLVS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 144,480,000
Market Cap $13M
Description
Clovis Oncology, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing anti-cancer agents in the United States, Europe, and internationally. In the U.S., the company offers Rubraca (rucaparib), an oral small molecule inhibitor of poly ADP-ribose polymerase for recurrent epithelial ovarian, fallopian tube, or pr...

Get notified when there are updates to the investment portfolio of Pacer Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Pacer Advisors, Inc. with notifications on news.